Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy

Exclusion Criteria

• •Known hypersensitivity to Zoladex, Casodex (if applicable), or any component of these product, or to other similar agents
• •Severe cardiac disease (New York Heart Association class III or greater)
• •Severe lung disease
• •Uncontrollable pain
• •Unstable bone lesion
• •Any co-morbidity restraining the patient's ability to walk alone or to modify his walking habits (eg Parkinson's disease, advanced multiple sclerosis, leg amputation, ...)
• •Any concomitant condition that would make it undesirable, in the physician's opinion, for the subject to participate in the trial or would jeopardize compliance with the protocol.
• •Any contraindication to undertake the 6-minutes walk test (unstable angina or myocardial infarction during the previous month, a resting heart rate of more than 180, systolic blood pressure of more than 180, and a diastolic pressure of more than 100). The patient must have his cardiovascular conditions stabilized and controlled before enrollment in the trial.
• •Unwillingness or incapacity to consent to trial participation.